November 8, 2012 / 11:57 AM / 5 years ago

Sun Pharma to buy Dusa for $230 mln

REUTERS - Sun Pharmaceutical Industries Ltd (SUN.NS) said it will acquire U.S. dermatology company Dusa Pharmaceuticals Inc (DUSA.O) for about $230 million to gain access to its light-based skin treatment platform.

Dusa shareholders will get $8 per share in cash, representing a 38 percent premium to Dusa's Wednesday stock close.

Dusa was advised by Leerink Swann on the deal, the companies said in a joint statement. (Reporting by Esha Dey in Bangalore; Editing by Roshni Menon)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below